|
MedStar Research
Institute is screening candidates with type 2 diabetes
treated with insulin for eligibility to enroll in a research study
looking at a new medication to treat diabetes.
Qualified
participants receive study related care by physicians, study medications and monetary compensation for
your time.
Please
call
MedStar Research Institute at
202-787-5318
for information
|
